Bulletin
Investor Alert

Centene Corp.

NYS: CNC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 2, 2021, 7:40 p.m.

CNC
/zigman2/quotes/208900023/composite

$

59.14

Change

0.00 0.00%

Volume

Volume 92,351

Quotes are delayed by 20 min

/zigman2/quotes/208900023/composite

Today's close

$ 59.39

$ 59.14

Change

-0.25 -0.42%

Day low

Day high

$59.05

$60.25

Open

52 week low

52 week high

$43.96

$74.70

Open

Company Description

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized p...

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Valuation

P/E Current

19.02

P/E Ratio (with extraordinary items)

19.06

P/E Ratio (without extraordinary items)

19.23

Price to Sales Ratio

0.31

Price to Book Ratio

1.35

Price to Cash Flow Ratio

6.32

Enterprise Value to Sales

0.48

Total Debt to Enterprise Value

0.34

Efficiency

Revenue/Employee

1,558,415.00

Income Per Employee

25,358.00

Total Asset Turnover

2.01

Liquidity

Current Ratio

1.08

Profitability

Operating Margin

3.36

Pretax Margin

2.50

Net Margin

1.63

Return on Assets

3.26

Return on Equity

9.44

Return on Total Capital

10.45

Return on Invested Capital

5.12

Capital Structure

Total Debt to Total Equity

71.07

Total Debt to Total Capital

41.54

Total Debt to Total Assets

26.23

Long-Term Debt to Equity

69.90

Long-Term Debt to Total Capital

40.86

Officers and Executives

Name Age Officer Since Title
Mr. Michael F. Neidorff 77 1996 Chairman, President & Chief Executive Officer
Ms. Brandy Burkhalter - 2015 Chief Operating Officer & Executive Vice President
Mr. Jeffrey A. Schwaneke 44 2008 Chief Accounting Officer, VP & Controller
Ms. Sarah London 39 2020 Senior VP-Technology, Innovation & Moderation
Dr. Ken Yamaguchi - 2015 Chief Medical Officer & Executive Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/11/2021 Orlando Lozano Ayala
Director
8,000   Disposition at $60.97 per share. 487,760
01/08/2021 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
11,250   Disposition at $70 per share. 787,500
01/06/2021 Brandy Burkhalter
EVP, Chief Operating Officer
8,000   Disposition at $67 per share. 536,000
12/31/2020 Robert K. Ditmore
Director
669   Award at $63.53 per share. 42,501
12/31/2020 Tommy George Thompson
Director
551   Award at $63.53 per share. 35,005
12/31/2020 John R. Roberts
Director
492   Award at $63.53 per share. 31,256
12/31/2020 Frederick H. Eppinger
Director
492   Award at $63.53 per share. 31,256
12/31/2020 David L. Steward
Director
551   Award at $63.53 per share. 35,005
12/31/2020 William L. Trubeck
Director
492   Award at $63.53 per share. 31,256
12/31/2020 H. James Dallas
Director
492   Award at $63.53 per share. 31,256
12/29/2020 Jeffrey A. Schwaneke
EVP, CFO
2,150   Gift at $0 per share. 0
12/28/2020 Michael F. Neidorff
Chairman, President & CEO; Director
45,000   Gift at $0 per share. 0
12/19/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
1,074   Derivative/Non-derivative trans. at $61.15 per share. 65,675
12/15/2020 Michael F. Neidorff
Chairman, President & CEO; Director
250,000   Award at $59.73 per share. 14,932,500
12/15/2020 Michael F. Neidorff
Chairman, President & CEO; Director
103,296   Award at $50.43 per share. 5,209,217
12/15/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
90,000   Award at $59.73 per share. 5,375,700
12/15/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
13,558   Award at $49.85 per share. 675,866
12/15/2020 Jeffrey A. Schwaneke
EVP, CFO
90,000   Award at $59.73 per share. 5,375,700
12/15/2020 Jeffrey A. Schwaneke
EVP, CFO
19,368   Award at $49.85 per share. 965,494
12/15/2020 Brandy Burkhalter
EVP, Chief Operating Officer
80,000   Award at $59.73 per share. 4,778,400
12/15/2020 Brandy Burkhalter
EVP, Chief Operating Officer
7,747   Award at $49.85 per share. 386,187
12/15/2020 Mark J. Brooks
EVP, Chief Information Officer
25,000   Award at $59.73 per share. 1,493,250
12/15/2020 Mark J. Brooks
EVP, Chief Information Officer
9,555   Award at $49.85 per share. 476,316
12/15/2020 Christopher Koster
SVP, Secr. & General Counsel
40,000   Award at $59.73 per share. 2,389,200
12/15/2020 Christopher Koster
SVP, Secr. & General Counsel
5,746   Award at $49.85 per share. 286,438
12/15/2020 David P. Thomas
EVP, MARKETS
25,000   Award at $59.73 per share. 1,493,250
12/15/2020 Christopher R. Isaak
SVP, Corporate Controller, CAO
2,105   Award at $49.85 per share. 104,934
12/15/2020 Michael F. Neidorff
Chairman, President & CEO; Director
132,145   Derivative/Non-derivative trans. at $59.73 per share. 7,893,020
12/15/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
17,345   Derivative/Non-derivative trans. at $59.73 per share. 1,036,016
12/15/2020 Jeffrey A. Schwaneke
EVP, CFO
24,778   Derivative/Non-derivative trans. at $59.73 per share. 1,479,989
12/15/2020 Brandy Burkhalter
EVP, Chief Operating Officer
9,911   Derivative/Non-derivative trans. at $59.73 per share. 591,984
12/15/2020 Mark J. Brooks
EVP, Chief Information Officer
12,224   Derivative/Non-derivative trans. at $59.73 per share. 730,139
12/15/2020 Christopher Koster
SVP, Secr. & General Counsel
7,351   Derivative/Non-derivative trans. at $59.73 per share. 439,075
12/15/2020 Christopher R. Isaak
SVP, Corporate Controller, CAO
2,693   Derivative/Non-derivative trans. at $59.73 per share. 160,852
12/15/2020 Richard A. Gephardt
Director
835   Gift at $0 per share. 0
12/13/2020 Michael F. Neidorff
Chairman, President & CEO; Director
18,092   Derivative/Non-derivative trans. at $60.71 per share. 1,098,365
12/12/2020 Michael F. Neidorff
Chairman, President & CEO; Director
15,273   Derivative/Non-derivative trans. at $60.71 per share. 927,223
12/12/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
2,507   Derivative/Non-derivative trans. at $60.71 per share. 152,199
12/12/2020 Jeffrey A. Schwaneke
EVP, CFO
3,581   Derivative/Non-derivative trans. at $60.71 per share. 217,402
12/12/2020 Brandy Burkhalter
EVP, Chief Operating Officer
1,433   Derivative/Non-derivative trans. at $60.71 per share. 86,997
12/12/2020 Mark J. Brooks
EVP, Chief Information Officer
1,767   Derivative/Non-derivative trans. at $60.71 per share. 107,274
12/12/2020 Christopher Koster
SVP, Secr. & General Counsel
1,063   Derivative/Non-derivative trans. at $60.71 per share. 64,534
12/12/2020 Christopher R. Isaak
SVP, Corporate Controller, CAO
390   Derivative/Non-derivative trans. at $60.71 per share. 23,676
/news/latest/company/us/cnc

MarketWatch News on CNC

  1. Here Are the 24 Most Undervalued Stocks Right Now

    5:30 a.m. Feb. 16, 2021

    - Al Root

  2. Here Are the 24 Most Undervalued Stocks Right Now

    5:30 a.m. Feb. 16, 2021

    - Al Root

  3. Under Armour Calls Timeout on Its Big NFL Deal

    5:28 p.m. Feb. 5, 2021

    - Teresa Rivas

  4. Centene Is Climbing on Its Plans to Buy Magellan Health

    11:36 a.m. Jan. 4, 2021

    - Josh Nathan-Kazis

  5. Magellan Health shares soar 11% premarket

    6:07 a.m. Jan. 4, 2021

    - Ciara Linnane

  6. Centene and Magellan expect deal to close in second half of 2021

    6:06 a.m. Jan. 4, 2021

    - Ciara Linnane

  7. Centene expects deal to be mildly accretive in first year, boost EPS by low to mid-single digit percent by year 2

    6:06 a.m. Jan. 4, 2021

    - Ciara Linnane

  8. Centene to pay $95 per Magellan share

    6:04 a.m. Jan. 4, 2021

    - Ciara Linnane

  9. Centene to acquire Magellan Health in deal with enterprise value of $2.2 bln

    6:04 a.m. Jan. 4, 2021

    - Ciara Linnane

  10. Centene sees 2021 revenue $114.1 bln-$116.1 bln; FactSet consensus $115.95 bln

    6:03 a.m. Dec. 18, 2020

    - Tomi Kilgore

  11. Loading more headlines...
/news/nonmarketwatch/company/us/cnc

Other News on CNC

  1. Humana (HUM), Mercy Tie Up to Extend Telehealth Services

    11:29 a.m. Feb. 26, 2021

    - Zacks.com

  2. IPO Update: InnovAge Seeks $300 Million IPO To Pay Down Debt

    11:20 a.m. Feb. 25, 2021

    - Seeking Alpha

  3. 10-K: CENTENE CORP

    4:46 p.m. Feb. 22, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. Oscar Health launches IPO of 31M shares

    7:30 a.m. Feb. 22, 2021

    - Seeking Alpha

  5. Community Health's (CYH) Q4 Earnings Surpass, Improve Y/Y

    12:19 p.m. Feb. 18, 2021

    - Zacks.com

  6. CVS Stock Is Poised to Ride the Coming Managed Care Wave

    7:29 a.m. Feb. 18, 2021

    - InvestorPlace.com

  7. Bear of the Day: Centene (CNC)

    6:08 a.m. Feb. 16, 2021

    - Zacks.com

  8. Clover Health: Growth Of Quality

    4:03 p.m. Feb. 12, 2021

    - Seeking Alpha

  9. Magellan Health (MGLN), Wellth Tie Up on Behavioral Change

    12:20 p.m. Feb. 11, 2021

    - Zacks.com

  10. Company News for Feb 10, 2021

    9:42 a.m. Feb. 10, 2021

    - Zacks.com

  11. Centene announces senior notes offering

    9:16 a.m. Feb. 10, 2021

    - Seeking Alpha

  12. Centene (CNC) Gets a Buy Rating from Merrill Lynch

    4:55 p.m. Feb. 9, 2021

    - SmarterAnalyst

  13. Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y

    9:37 a.m. Feb. 9, 2021

    - Zacks.com

  14. Centene Q4 topline up 50%, misses consensus

    8:16 a.m. Feb. 9, 2021

    - Seeking Alpha

  15. Centene (CNC) Tops Q4 Earnings Estimates

    7:30 a.m. Feb. 9, 2021

    - Zacks.com

  16. Loading more headlines...

At a Glance

Centene Corp.

7700 Forsyth Boulevard

St. Louis, Missouri 63105

Phone

1 3147254477

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$111.12B

Net Income

$1.81B

2020 Sales Growth

48.9%

Employees

-

/news/pressrelease/company/us/cnc

Press Releases on CNC

  1. Centene Corporation Announces Executive Leadership Appointments

    7:00 a.m. March 1, 2021

    - PR Newswire - PRF

  2. Centene To Present At Two Virtual Healthcare Conferences In March

    8:00 a.m. Feb. 24, 2021

    - PR Newswire - PRF

  3. How to trade Centene $CNC With Risk Controls

    1:27 a.m. Feb. 16, 2021

    - Stock Traders Daily

  4. Dr. Anne Walentik Receives Annual Summit Award for Excellence in Care

    7:00 a.m. Feb. 11, 2021

    - PR Newswire - PRF

  5. Centene Corporation Prices Offering of Senior Notes

    6:46 p.m. Feb. 10, 2021

    - PR Newswire - PRF

  6. Centene Corporation Announces Offering of Senior Notes

    8:43 a.m. Feb. 10, 2021

    - PR Newswire - PRF

  7. Centene Corp. to Host Earnings Call

    6:30 a.m. Feb. 9, 2021

    - ACCESSWIRE

  8. Centene Corporation Reports 2020 Results

    6:00 a.m. Feb. 9, 2021

    - PR Newswire - PRF

  9. Loading more headlines...
Link to MarketWatch's Slice.